MADISON, N.J.--(BUSINESS WIRE)--Apr 1, 2024--
Transcend Capital Advisors has signed a multi-year Name, Image, and Likeness (NIL) partnership with 16-year-old amateur golfer Gianna Clemente. Clemente is currently the #2-ranked golfer in the American Junior Golf Association (AJGA) rankings and #32 in the Women’s World Amateur Golf Rankings (WAGR).
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240401200617/en/
A resident of Estero, Florida, and four-time AJGA All-American, Clemente won her first tournament when she was five years old and burst onto the national golf scene in 2019 when she qualified for the U.S. Women’s Amateur Championship at just 11 years of age. In 2022, at age 14, Clemente became the youngest player to make it into three straight LPGA Tour events via Monday Qualifiers. Clemente was recently named to the inaugural U.S. National Junior Team and was a member of last year’s Junior Ryder Cup Team, competing for the USA in Rome, Italy, alongside fellow Transcend Golf team members Miles Russell and Yana Wilson.
This week, Clemente will tee it up for the second consecutive year at the Augusta National Women’s Amateur, where in 2023, as the youngest competitor in the field, she finished tied for 14 th place.
“Transcend Golf was created to invest in some of the game’s most talented amateur players and to help them achieve their dreams of playing professional golf,” said Brian Gorczynski, Managing Partner of Transcend. “Gianna has established herself as one of the brightest stars in the game and her accomplishments speak for themselves. We are thrilled to welcome her to Team Transcend and are excited to watch all that she will achieve over the course of her career.”
Clemente’s career includes winning the 2023 South Atlantic Women’s Amateur Championship, “The Sally,” which is the oldest women’s amateur tournament in the country; her even-par total over four rounds won the event by one shot. Clemente is also the youngest-ever winner of the AJGA Ping Invitational, which she won at age 13 in 2021 and again in 2022.
Last summer, Clemente followed a semi-final appearance at the U.S Girls’ Junior Championship with a victory at the Junior PGA Championship, shooting 9-under par to win by three strokes. She capped off a stellar 2023 season by also representing the USA at the PING Junior Solheim Cup, where she teamed up with Wilson in the Fourball Matches.
“My family and I have watched the momentum building at Transcend Golf for the last year and I could not be more excited to join Team Transcend,” said Clemente. “The team they have built is truly amazing and I am humbled to become part of such a great group. I am grateful for Transcend’s commitment to amateur golf and their support will allow me to continue growing into the best player that I can be.”
Transcend also has NIL partnerships with Ben James, 20, a sophomore at the University of Virginia who is currently ranked #5 in the Men’s World Amateur Golf rankings; Yana Wilson, 17, currently the #1-ranked junior girl in the Rolex AJGA Rankings; Blades Brown, 16, #5 in the Rolex AJGA Boys Ranking and the 2023 Tennessee Men’s and Junior Player of the Year; and Miles Russell, 15, currently the #1-ranked junior boy in the Rolex AJGA Rankings. The firm previously had a multi-year NIL partnership with Caleb Surratt, who turned professional earlier this year.
About Transcend Capital Advisors
Founded in 2019 and headquartered in Madison, New Jersey, Transcend is an independent registered investment advisor (RIA) offering wealth management services, public and private investments, strategic advisory services, and access to banking, lending, and family office solutions. Transcend is an employee-owned firm and manages approximately $3.0 billion of assets, serving families, business owners, executives, retirees, and entrepreneurs across the United States. Leveraging the unique network of its experienced management team, Transcend provides clients with access to investment opportunities not typically available to individual investors. Transcend was recently ranked #42 in the United States in Forbes’ second annual “America’s Top RIA Firms” list and was also recently named in the 2023 SmartAsset “100 Fastest Growing RIAs” list. For more information on Transcend, please visit transcendcapital.com.
The Forbes “America’s Top RIA Firms” list was compiled by SHOOK Research, which uses quantitative and qualitative data, including interviews, to rank firms. Firms elect to participate but do not pay to be included in the ranking. To learn more about the methodology, click here.
SmartAsset compiled its ranking of U.S.-based investment advisors registered with the U.S. Securities & Exchange Commission (SEC) by examining filing data and ranking firms based on one-year and three-year growth of client accounts and assets under management. No compensation was paid for inclusion in this ranking. To learn more about the methodology, click here.
(Photo: Business Wire)
As the U.S. government moves toward reclassifying marijuana as a less dangerous drug, there may be little immediate impact in the dozen states that have not already legalized cannabis for widespread medical or recreational use by adults.
But advocates for marijuana legalization hope a federal regulatory shift could eventually change the minds — and votes — of some state policymakers who have been reluctant to embrace weed.
“It is very common for a state legislator to tell me, ‘Well, I might be able to support this, but ... I’m not going to vote for something that’s illegal under federal law,’” said Matthew Schweich, executive director of the Marijuana Policy Project, which advocates for cannabis legalization.
Although a proposal to reclassify marijuana would not make it legal, “it is a historic and meaningful change at the federal level that I think is going to give many state lawmakers a little less hesitation to support a bill,” Schweich added.
The U.S. Drug Enforcement Administration has proposed to shift marijuana from a “Schedule I” drug, which includes heroin and LSD, to a less tightly regulated “Schedule III” drug, which includes ketamine and some anabolic steroids. Federal rules allow for some medical uses of Schedule III drugs. But the proposed change faces a lengthy regulatory process, which may not be complete until after the presidential election.
In the meantime, the proposed federal change could add fresh arguments for supporters of ballot measures seeking to legalize marijuana. Florida voters will decide on a constitutional amendment allowing recreational cannabis this November. Public votes could also be held in several other states, including South Dakota, where supporters plan to submit signatures Tuesday for a third attempt at legalizing recreational marijuana.
Following two previous failed attempts, a Nebraska group is gathering signatures to get two measures onto this year’s ballot: one to legalize medical marijuana and another to allow private companies to grow and sell it.
In North Dakota, criminal defense attorney Mark Friese is a former police officer who is backing a marijuana legalization ballot initiative. He said the proposed federal reclassification could immensely help this year's initiative campaign. North Dakota voters rejected legalization measures in 2018 and 2022 but approved medical marijuana in 2016.
“The bottom line is the move is going to allow intelligent, informed discussion about cannabis legislation instead of succumbing to the historical objection that marijuana is a dangerous drug like LSD or black tar heroin,” Friese said.
Others aren't so sure the reclassification will make a difference.
Jackee Winters, chairperson of an Idaho group backing a ballot initiative to legalize medical marijuana, said it's tough to get would-be supporters to sign their petition.
“People are literally afraid to sign anything in Idaho that has to do with marijuana,” she said. “They’re afraid the cops will be coming to their house."
The proposed federal change may have little affect in 24 states that already legalized recreational marijuana for adults, or in an additional 14 states that allow medical marijuana. But advocates hope it could sway opinions in a dozen other states that either outlaw cannabis entirely or have limited access to products with low levels of THC, the chemical that makes people high.
Georgia has allowed patients with certain illnesses and physician approval to consume low-THC cannabis products since 2015. But until last year, there was no legal way to buy them. Eight dispensaries are now selling the products.
The Georgia Board of Pharmacy last year also issued licenses for low-THC products to 23 independent pharmacies, but the federal DEA in November warned pharmacies that dispensing medical marijuana violated federal law.
Dawn Randolph, executive director of the Georgia Pharmacy Association, said a federal reclassification of marijuana could open the way for pharmacists to treat marijuana products “like every other prescription medication.”
In other states, such as Tennessee, elected leaders remain hesitant to back either medical or recreational marijuana. Tennessee Senate Speaker Randy McNally, a Republican, previously said he wouldn’t support changing state law until the federal government reclassifies marijuana.
But after reports about the DEA’s recommended reclassification, McNally still held off on supporting any push to legalize medical marijuana.
Removing marijuana as a Schedule I drug “would only start the conversation in my mind. It would not end it. There would still be many issues to resolve if the downgrade to Schedule III happens as proposed,” he said Thursday.
A proposal to legalize medical marijuana died in a Kansas Senate committee without a vote this year, and an attempt to force debate in the full Senate failed by a wide margin. The strongest and most influential opposition came from law enforcement officials, who raised concerns that any legalization could invite organized crime and make it difficult to assess whether people are driving under the influence.
Kansas Bureau of Investigation Director Tony Mattivi considers the DEA effort to reschedule marijuana “misguided and politicized,” KBI spokesperson Melissa Underwood said.
The head of the South Carolina state police force also has opposed efforts to legalize medical marijuana, saying it opens the door to other drug use. A legalization bill backed by Republican state Sen. Tom Davis passed the Senate this year but has stalled in a House committee.
“It’s difficult to rewire a lot of people who have been conditioned to think of marijuana in a certain way,” said Davis, who vowed to push a medical marijuana bill again next year if reelected.
Although not fully embracing medical marijuana, Iowa and Texas both have laws allowing limited access to some cannabis products with low levels of THC. Some Texas cities have passed ordinances allowing small amounts of marijuana. But a similar effort in Lubbock, home to Texas Tech University, was derided in a Facebook post by Republican state Rep. Dustin Burrows as part of “nationwide effort by the left to undermine public safety.”
In Wyoming, a decade of pro-marijuana efforts through ballot initiatives and legislation has gotten nowhere. Gov. Mark Gordon, a Republican, has been ambivalent about legalizing medical marijuana and opposes legal recreational pot. The GOP-led Legislature didn’t even debate the latest bill to decriminalize marijuana and legalize medical marijuana.
Yet one organizer, who helped unsuccessful petition efforts in 2022 and 2023, hopes federal reclassification of marijuana nudges more lawmakers to support legalization.
“Resistance will be a lot less palpable,” legalization advocate Apollo Pazell said.
Associated Press writers Jeff Amy in Atlanta, Margery Beck in Omaha, Nebraska, Rebecca Boone in Boise, Idaho; Acacia Coronado in Austin, Texas; Jeffrey Collins in Columbia, South Carolina, Jack Dura in Bismarck, North Dakota, Hannah Fingerhut in Des Moines, Iowa, Mead Gruver in Cheyenne, Wyoming, John Hanna in Topeka, Kansas, and Kimberlee Kruesi in Nashville, Tennessee, contributed to this report.
FILE - A protester who supports medical marijuana holds a sign outside the Augusta Civic Center where the state legislature was meeting, Wednesday, April 28, 2021, in Augusta, Maine. A federal proposal to reclassify marijuana as a less dangerous drug has raised the hopes of some pot backers that more states will embrace cannabis. (AP Photo/Robert F. Bukaty, File)
FILE - Marijuana plants display buds as they are in the flowering stage at the indoor growing facility of Mockingbird Cannabis in Raymond, Miss., Jan. 20, 2023. A federal proposal to reclassify marijuana as a less dangerous drug has raised the hopes of some pot backers that more states will embrace cannabis. (AP Photo/Rogelio V. Solis, File)
FILE - Kay Nelson, left, and Bryan Grode, retried seniors from Laguna Woods Village, chat in the lobby of Bud and Bloom cannabis dispensary while waiting for a free shuttle to arrive in Santa Ana, Calif., Feb. 19, 2019. A federal proposal to reclassify marijuana as a less dangerous drug has raised the hopes of some pot backers that more states will embrace cannabis. (AP Photo/Jae C. Hong, File)
FILE - An indoor cannabis farm in Gardena, Calif., is seen, Aug. 15, 2019. Marijuana advocates are gearing up for Saturday, April 20, 2024. A federal proposal to reclassify marijuana as a less dangerous drug has raised the hopes of some pot backers that more states will embrace cannabis. (AP Photo/Richard Vogel, File)
FILE - Young marijuana plants have state mandated identification tags in the indoor growing facility of Mockingbird Cannabis in Raymond, Miss., Friday, Jan. 20, 2023. A federal proposal to reclassify marijuana as a less dangerous drug has raised the hopes of some pot backers that more states will embrace cannabis. (AP Photo/Rogelio V. Solis, File)
